PMID: 6170655Nov 1, 1981Paper

The problem of lindane

Journal of the American Academy of Dermatology
J E Rasmussen

Abstract

The human clinical use of 1% lindane formulations has become somewhat controversial during the past five years. This review is an in-depth report of the efficacy and safety of 1% lindane compared with the agents that have been preferred as alternative. Almost all of the suspected adverse drug reactions (ADR) from 1% lindane have involved substantial misuse. The number of suspected ADRs remains small, especially when compared with the magnitude of human clinical use of 1% lindane preparations in the United States (50 million ounces during the past five years). One percent lindane should continue to remain the preparation of choice for nearly all patients with scabies and lice, but dermatologists should appreciate that these views are not necessarily shared by all health professionals. Consequently, it is most appropriate to explain the possible side effects from misuse of lindane to each patient. This brief period of patient education is time well spent--it will help maintain proper compliance and allay the upset that many of your patients may have if they encounter negative opinions about lindane in the lay and medical press or from other health professionals.

References

Dec 1, 1976·Toxicology and Applied Pharmacology·J P HanigS Krop
Jan 1, 1979·Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes·S K KashyapS K Chatterjee
Aug 1, 1973·American Journal of Diseases of Children·S Hurwitz
Jul 1, 1970·British Journal of Industrial Medicine·G Czeglédi-Jankó, P Avar
Apr 1, 1974·Toxicology and Applied Pharmacology·R J Feldmann, H I Maibach

❮ Previous
Next ❯

Citations

Jan 1, 1984·Archives of Dermatological Research·E MenczelR Wester
Aug 9, 2001·Irish Journal of Medical Science·L A Murphy, C Buckley
Nov 30, 1988·Toxicology·J Portig, C Schnorr
Oct 27, 2004·Annales de dermatologie et de vénéréologie·S MostinckxM de la Brassinne
May 1, 1990·International Journal of Dermatology·B F O'DonnellF C Powell
Oct 1, 1991·International Journal of Dermatology·L C ParishL E Millikan
Jul 1, 1990·Zentralblatt für Veterinärmedizin. Reihe A·E SitarskaW Kluciński
Jul 1, 1984·Pediatric Dermatology·J E Rasmussen
Sep 1, 1994·Pediatric Dermatology·M J Quarterman, J L Lesher
Dec 3, 1998·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·J E Díaz
Jan 11, 2005·Postgraduate Medical Journal·K Karthikeyan
Jul 24, 2001·Drugs·T C RoosD R Bickers
Aug 2, 2003·American Journal of Public Health·Martin BelsonCarol Rubin
Apr 16, 2004·Journal of Toxicology. Clinical Toxicology·Mathias B ForresterSharilyn K Stanley
Feb 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·K D LempertF C Whittier
May 9, 2006·Dermatologic Clinics·Sancy A Leachman, Barbara R Reed
Jul 1, 1983·International Journal of Dermatology·L C ParishR Schwartzman
Jun 30, 2015·Indian Journal of Dermatology·Prashant Verma, Chaitanya Namdeo
Mar 1, 1983·The Physician and Sportsmedicine·L W Stauffer
Aug 1, 1991·The British Journal of Dermatology·D A Burns
Aug 1, 1984·The Australasian Journal of Dermatology·J E Rasmussen
Dec 1, 1983·International Journal of Dermatology·L C ParishS A Kucirka
May 1, 1983·Postgraduate Medicine·R J Caserio
Feb 1, 1996·Pediatric Annals·C M Peterson, L F Eichenfield
Apr 30, 1983·The Medical Journal of Australia·C A Commens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Dermatology
L M SolomonD P West
Archives of Dermatology
J E Rasmussen
Sexually Transmitted Diseases
Jillian L PierzchalskiSteven C Matson
© 2021 Meta ULC. All rights reserved